ASTRO 2023 Annual Meeting

The American Society for Radiation Oncology (ASTRO) Annual Meeting is considered the premier scientific event for radiation oncology in the world. Leaders from the Mass General Cancer Center are honored to join their international colleagues at ASTRO 2023, held October 1-4, 2023, in San Diego, California with a virtual attendance option. 

This year's theme is "Pay It Forward: Partnering With Our Patients" and features late breaking research presentations and dynamic networking events throughout the conference. Over 1,300 posters and 300 abstracts will cover all the major disease sites, digital innovations, palliative care, and diversity, equity, and inclusion. Nearly 50 faculty members from the Mass General Cancer Center are scheduled to present their latest research at the conference, with topics including climate advocacy in oncology care, artificial intelligence, advanced radiation technologies, telemedicine, and much more.

Hazim Ababneh, MB

Predictors of Locoregional Recurrence and Distant Failure After Neoadjuvant Chemotherapy Among Patients Treated With Mastectomy Versus Breast-conserving Surgery
October 2 at 3:00 p.m. - 4:00 p.m. PT
Hall B2

Outcomes of Bridging and Salvage Radiotherapy in Relapsed or Refractory Mantle Cell Lymphoma Patients Undergoing CD19-Targeted CAR T-Cell Therapy
October 3 at 4:00 p.m. - 5:00 p.m. PT
Hall B2

Carolyn Baek, PT, DPT, CLT, OCS

Timing of Physical Therapy to Optimize Shoulder Range of Motion Among Patients Receiving Breast Radiotherapy
October 2 at 3:00 p.m. - 4:00 p.m. PT
Hall B2

Stephanie Bennett, PhD

Theranostic Nanoparticle Uptake in Patient Brain Tumors as Quantified by MP2RAGE T1 Mapping
October 2 at 11:15 a.m. - 11:22 a.m. PT
Room 30 A/B/C

Graham Boyd, MD

Radiation Treatment Plan Evaluation Education in Residency: A Needs Assessment
October 3 at 5:15 p.m. - 6:15 p.m. PT
Hall B2

Annie Chan, MD

Discussant in SS 23 - H&N 2: Virus-associated Head & Neck Cancers: From Screening to Treatment
October 3 at 3:20 p.m. - 3:30 p.m. PT
Room 1

Demystifying the Role of Radiation Dose Bath in Brain Injury Using Machine Learning
October 3 at 4:00 p.m. - 5:00 p.m. PT
Hall B2

Juliane Daartz, PhD

A Potential Cause for Unexplained Radiation Toxicity in Proton Therapy
October 2 at 10:45 a.m. - 12:00 p.m. PT
Hall B2

Jason A. Efstathiou, MD, DPhil

Introduction: Keynote Address 02 - Keynote 02: Random Acts of Medicine
October 3 at 9:15 a.m. - 9:17 a.m. PT
Ballroom 20

Myrsini Ioakeim-Ioannidou, MD

Proton vs. Photons for Breast Cancer Patients With Immediate, Implant-based Reconstruction Receiving Postmastectomy Radiotherapy: A Multicenter Pooled Analysis
October 4 at 12:40 p.m. - 12:45 p.m. PT
Room 8

Multi-institutional Phase I Feasibility Trial of Vertebral Body Sparing CSI for Pediatric Brain Tumors
October 3 at 5:15 p.m. - 6:15 p.m. PT
Hall B2

Rachel Jimenez, MD

Holistic Review and Recruitment
October 3 at 4:25 p.m. - 4:36 p.m. PT
Room 32

Sophia Kamran, MD

Prospective Validation of Single Nucleotide Polymorphisms as Predictors of Gastrointestinal, Genitourinary, and Sexual Patient-reported Outcomes Following Radiotherapy for Prostate Cancer
October 3 at 2:30 p.m. - 3:45 p.m. PT
Hall B2

Florence (Katie) Keane, MD

Contralateral Esophagus Sparing Is Associated With Lack of Severe Esophagitis in Patients With Limited Stage SCLC Treated With QD or BID Chemoradiotherapy Regimens
October 1 at 4:45 p.m. - 6:00 p.m. PT
Hall B2

Melin Khandekar, MD, PhD

Hippocampal Avoidance Whole Brain Radiotherapy With Reduced Whole Brain Dose Enables Sparing of Hippocampi Without Increased Risk of Distant Brain Failure in Non-small Cell Lung Cancer
October 2 at 10:45 a.m. - 12:00 p.m. PT
Hall B2

Julie Koenig, MD

Association Between Liver Metastases and Treatment Response in Patients With Metastatic, Microsatellite Stable Colorectal Cancer Treated With Radiation Therapy and Dual Immune Checkpoint Blockade
October 3 at 12:45 p.m. - 2:00 p.m. PT
Hall B2

Nayan Lamba

A Genomic Score to Predict Local Control Among Patients With Brain Metastases Managed With Radiation
October 2 at 10:45 a.m. - 12:00 p.m. PT
Hall B2

Genomic Predictors of Leptomeningeal Disease Development Among Patients With Brain Metastases
October 3 at 3:13 p.m. - 3:20 p.m. PT
Room 6 C/F

Dalia Larios, MD

Moderator for the EDU 40 - ASTRO/CHEST Joint Session - Paying It Forward: Building Resilient Oncology Systems Through Climate Policy and Advocacy
October 4 at 8:00 a.m. - 9:00 a.m. PT
Room 30 D/E

Introduction to Climate Policy
October 4 at 8:00 a.m. - 8:02 a.m. PT
Room 30 D/E

Climate Advocacy in Oncology Care: How Can Health Providers Influence Change?
October 4 at 8:36 a.m. - 8:47 a.m. PT
Room 30 D/E

Using Life Cycle Assessment as a Tool to Evaluate the Environmental Impact of Radiation Oncology and Inform Treatment Decision-making in Early-stage Breast Cancer
October 4 at 10:30 a.m. - 11:45 a.m. PT
Hall B2

Grace Lee, MD

Adjuvant Radiotherapy in Atypical Meningioma: Are the Risks Worth the Benefit?
October 2 at 10:45 a.m. - 12:00 p.m. PT
Hall B2

Katie Lee, MD, PhD

Clinical Outcomes With Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer: Results From a Prospective Registry Trial
October 2 at 10:45 a.m. - 12:00 p.m. PT
Hall B2

A Single-institution Experience of Acute Neuropathic Lumbosacral Pain in Patients Treated With Short Course Hypofractionated Radiotherapy in Locally Advanced Rectal Cancer
October 3 at 12:45 p.m. - 2:00 p.m. PT
Hall B2

Artificial Intelligence-derived Dominant Intraprostatic Lesion Volume Predicts Indications for Adjuvant Radiation After Radical Prostatectomy
October 3 at 2:30 p.m. - 3:45 p.m. PT
Hall B2

Shannon MacDonald, MD

Telemedicine: Potential Influence of Climate Research on Policy and Practice
October 4 at 8:25 a.m. - 8:36 a.m. PT
Room 30 D/E

Ariel Marciscano, MD

Elective Nodal Irradiation and Radiation-immunotherapy Combinations: Biological and Clinical Insights
October 2 at 5:00 p.m. - 6:00 p.m. PT
Room 30 A/B/C

Introductions and a Primer on Radiation-induced Immunity and the Critical Role of Tumor-associated Draining Lymph Nodes
October 2 at 5:00 p.m. - 5:11 p.m. PT
Room 30 A/B/C

Longitudinal Profiling of Tumor RNA Expression Signatures Reveal Key Biological Features Associated With Response to Neoadjuvant Stereotactic Body Radiation Therapy in High-risk Prostate Cancer
October 2 at 5:00 p.m. - 6:00 p.m. PT
Hall B2

Javier Mora, MD

A U.S. Cancer Centers Interactive Cancer Education Program for Spanish-speaking Latinos During COVID-19 Pandemic
October 1 at 4:45 p.m. - 6:00 p.m. PT
Hall B2

Radiation-associated Lymphopenia in Advanced Prostate Cancer Treated With Contemporary Radiation Techniques
October 3 at 2:30 p.m. - 3:45 p.m. PT
Hall B2

George Naoum, MD, MS

Is it the Type of Axillary Surgery or the Number of Removed Lymph Nodes That Increases the Risk of Breast Cancer Related Lymphedema (BCRL)? Results From a Prospective Screening Trial
October 2 at 5:00 p.m. - 5:07 p.m. PT
Room 6 C/F

Comparison Between Pre-Pectoral and Post-Pectoral Implant Reconstruction and Different Radiation Modalities on Breast Reconstruction Complications
October 2 at 5:40 p.m. - 5:47 p.m. PT
Room 6 C/F

Omission of Chest Wall/Scar Boost and Skin Bolus Does Not Increase Risk of Local Recurrence for Breast Cancer Patients
October 2 at 3:00 p.m. - 4:00 p.m. PT
Hall B2

Alicia "Lish" Smart, MD

Strategies for Discussing Sexual Health With SGM and Non-SGM Patients With Cancer
October 4 at 8:02 a.m. - 8:14 a.m. PT
Room 4

Tafadzwa Chaunzwa, MD

AI-derived CT Body Composition in Advanced Non-small Cell Lung Cancer: A Multicohort Study
October 1 at 4:45 p.m. - 6:00 p.m. PT
Hall B2

Alphonse Taghian, MD, PhD

Increased Complication Rates With Proton Therapy in Breast Cancer Patients With Immediate, Implant-based Reconstruction: Single-institution Comparative Effectiveness Analysis
October 2 at 5:10 p.m. - 5:17 p.m. PT
Room 6 C/F

Nancy Tarbell, MD, FASTRO

Strategies for Managing Experiences With Discrimination in the Workplace: Perspective of a Faculty Dean
October 3 at 8:10 a.m. - 8:18 a.m. PT
Room 32

Henning Willers, MD

Moderator for QP 12 - Bio 6: Tumor and Radiation Biology
October 3 at 4:00 p.m. - 5:00 p.m. PT
Room 8

Landscape of the Radiosensitizing Properties of Targeted Agents From the NCI CTEP Portfolio Across Genomically Diverse 3D Tumor Models
October 4 at 12:30 p.m. - 12:37 p.m. PT
Room 2

Brian Winey, PhD

Moderator for SS 12 - Phys 3: FLASH and Novel Techniques
October 2 at 3:00 p.m. - 4:00 p.m. PT
Room 30 A/B/C

Amy Wisdom, MD, PhD

Health-related Quality of Life Analysis in Patients With Non-functioning Pituitary Macroadenomas Treated With Transsphenoidal Surgery With or Without Radiation Therapy
October 2 at 3:00 p.m. - 4:00 p.m. PT
Hall B2

Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
October 3 at 2:30 p.m. - 3:45 p.m. PT
Hall B2

Jennifer Wo, MD

Being an Effective Mentor for Residents
October 3 at 2:47 p.m. - 3:02 p.m. PT
Room 30 A/B/C

Torunn Yock, MD

Digital Health and Health Outcomes
October 3 at 1:27 p.m. - 1:47 p.m. PT
Room 2

Lin Zhu, MD

Contralateral Esophagus Sparing Prevents Symptomatic Esophagitis in Ultra-central NSCLC Receiving Hypofractionated Radiotherapy
October 1 at 4:45 p.m. - 6:00 p.m. PT
Hall B2